funder-graph

FundersNY

Grants paid by Job Research Foundation

EIN 35-7211744 · New York, NY · Form 990-PF, Part XV · NTEE T20

Job Research Foundation of New York, NY (EIN 35-7211744) reported 20 grants paid totaling $2,000,272 to 15 recipients in tax years 2020–2024, on Form 990-PF, Part XV. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.

Grants paid

$2,000,272

20 grants

Recipients

15

distinct organizations

Tax years

2020–2024

4 filings in the corpus

By tax year

Grants by tax year, as the same figures
Tax yearGrants paidAmount paidApproved for future
20208$800,272
20225$500,000
20234$400,000
20243$300,000

Top recipients

The 15 recipients receiving the most from Job Research Foundation, by grants paid, out of 15 distinct recipients.

Recipients ranked by total grants paid
RecipientMatchLocationGrantsTotal paidLatest year
University of Newcastle Upon TyneU2$200,0002022
Helmholtz Zentrum MunchenUNeuherberg, NEUHERBERG2$200,0002023
Icahn School of Medicine at Mount Sinai 13-6171197BNew York City, NY2$200,0002024
National Institute of Allergy and Infectious Diseases 52-0599025DBethesda, MD2$200,0002023
Garvan Institute of Medical ResearchUSydney, SYDNEY2$200,0002024
Klinikum Rechts Der Isar Der Technischen Universitat MunchenUMunchen, MUNCHEN1$100,2722020
The Rockefeller University 13-1624158BNew York, NY1$100,0002020
University of NswUSydney, SYDNEY1$100,0002020
Aarhus University Department of BiomedicineUDenmark1$100,0002024
Boston Children's HospitalUBoston, MA1$100,0002020
University of FreiburgUFreiburg, FREIBURG1$100,0002022
The General Hospital Corporation DBA the Massachusetts General HospitalUBoston, MA1$100,0002020
Trustees of the University of Pennsylvania 23-1352685BPhiladephia, PA1$100,0002020
Fundacion Publica Andaluza Para la Gestion de Investigacion En Salud de SevUSeville, SEVILLE1$100,0002020
Columbia University 82-2244803CNew York, NY1$100,0002022

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Every grant

All 20 grant rows this organization reported, most recent first.

Grants reported by Job Research Foundation
Tax yearRecipientMatchAmountTypePurposeSource filing
2024Garvan Institute of Medical Research Sydney, SYDNEYU$100,000paidCARRYING OUT RESEARCH INTO IMMUNE DYSREGULATION IN JOB SYNDROME- ELUCIDATING MECHANISMS OF STAT3- MEDIATED HOST DEFENSE, HUMORAL IMMUNITY AND IMMUNE- MEDIATED LUNG PATHOLOGY202533109349100303
2024Icahn School of Medicine at Mount Sinai New York City, NYB$100,000paidCARRYING OUT RESEARCH INTO CROSS REGULATION OF STAT SIGNALING PATHWAYS IN LUNG PATHOLOGY OF EXPERIMENTAL HIES202533109349100303
2024Aarhus University Department of Biomedicine DenmarkU$100,000paidCARRYING OUT RESEARCH INTO NEXT GENERATION CRISPR/CAS-BASED EX VIVO GENE EDITING OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS AS A CURATIVE TREATMENT OF JOB SYNDROME202533109349100303
2023Garvan Institute of Medical Research Sydney, SYDNEYU$100,000paidCARRYING OUT RESEARCH INTO IMMUNE DYSREGULATION IN JOB SYNDROME- ELUCIDATING MECHANISMS OF STAT3- MEDIATED HOST DEFENSE, HUMORAL IMMUNITY AND IMMUNE- MEDIATED LUNG PATHOLOGY202413169349100806
2023Helmholtz Zentrum Munchen Neuherberg, NEUHERBERGU$100,000paidCARRYING OUT RESEARCH INTO THE EVALUATION OF ALVEOLAR FUNCTION, REGENERATION AND GENE REPAIR IN JOB SYNDROME202413169349100806
2023National Institute of Allergy and Infectious Diseases Bethesda, MDD$100,000paidCARRYING OUT RESEARCH INTO THE NEXT-GENERATION CRISPR BASE EDITING APPROACHES TO TREAT JOB SYNDROME.202413169349100806
2023Icahn School of Medicine at Mount Sinai New York City, NYB$100,000paidCARRYING OUT RESEARCH INTO CROSS REGULATION OF STAT SIGNALING PATHWAYS IN LUNG PATHOLOGY OF EXPERIMENTAL HIES202413169349100806
2022National Institute of Allergy and Infectious Diseases Bethesda, MDD$100,000paidCARRYING OUT RESEARCH INTO THE NEXT-GENERATION CRISPR BASE EDITING APPROACHES TO TREAT JOB SYNDROME.202333179349102783
2022University of Newcastle Upon TyneU$100,000paidCARRYING OUT RESEARCH INTO THE QUALITY OF LIFE OF PATIENTS WITH AD-HIES, WITH PARTICULAR FOCUS ON THE IMPACT OF TREATMENT ON RESPIRATORY, DERMATOLOGICAL AND PSYCHOLOGICAL HEALTH.202333179349102783
2022University of Freiburg Freiburg, FREIBURGU$100,000paidTO CARRY OUT RESEARCH FOR TREATING HYPERIGESYNDROME BY GENOME EDITING IN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS.202333179349102783
2022Columbia University New York, NYC$100,000paidTO CARRY OUT RESEARCH INTO THE ROLE OF FIBEROBLAST SPECIFIC STAT3 EXPRESSION IN PNEUMATOCELE DEVELOPMENT AND GASTROINTESTINAL PERFORATION IN AD-HIES202333179349102783
2022Helmholtz Zentrum Munchen Neuherberg, NEUHERBERGU$100,000paidCARRYING OUT RESEARCH INTO THE EVALUATION OF ALVEOLAR FUNCTION, REGENERATION AND GENE REPAIR IN JOB SYNDROME202333179349102783
2020Klinikum Rechts Der Isar Der Technischen Universitat Munchen Munchen, MUNCHENU$100,272paidTO CARRY OUT RESEARCH INTO FIGHTING STAPHYLOCOCCUS AUREUS INFECTIONS AT THE MUCOSAL SURFACE IN JOB SYNDROME.202101349349102070
2020The General Hospital Corporation DBA the Massachusetts General Hospital Boston, MAU$100,000paidCARRYING OUT RESEARCH FOR THE PROJECT ENTITLED, "IMPAIRED EPITHELIAL DIFFERENTIATION AND HOST DEFENSE AS A MECHANISM FOR PULMONARY COMPLICATIONS IN JOB SYNDROME PATIENTS".202101349349102070
2020University of Newcastle Upon TyneU$100,000paidCARRYING OUT RESEARCH INTO THE QUALITY OF LIFE OF PATIENTS WITH AD-HIES, WITH PARTICULAR FOCUS ON THE IMPACT OF TREATMENT ON RESPIRATORY, DERMATOLOGICAL AND PSYCHOLOGICAL HEALTH.202101349349102070
2020Boston Children's Hospital Boston, MAU$100,000paidINVESTIGATING A NON TRANSCRIPTIONAL ROLE FOR IL-STAT3 IN MITOCHONDRIAL METABOLISM AND AD-HIES.202101349349102070
2020Fundacion Publica Andaluza Para la Gestion de Investigacion En Salud de Sev Seville, SEVILLEU$100,000paidTO CARRY OUT RESEARCH INTO THE UNDERLYING MECHANISM LIKELY CONTRIBUTING TO THE PATHOGENESIS OF PULMONARY COMPLICATIONS IN PATIENTS WITH AUTOSOMAL DOMINANT-HYPER IGE SYNDROME USING RUXOLITINIB (JAK - INHIBITOR TO SPECIFICALLY TARGET THIS PATHWAY ALTERATION).202101349349102070
2020Trustees of the University of Pennsylvania Philadephia, PAB$100,000paidCARRYING OUT RESEARCH INTO USING NEUTROPHIL-AVID NANOCARRIERS TO TREAT THE RECURRENT LUNG INFECTIONS THAT ARE COMMON IN PATIENTS WITH JOB SYNDROME.202101349349102070
2020University of Nsw Sydney, SYDNEYU$100,000paidRESEARCH INTO STAT3-MEDIATED REGULATION OF THE HUMAN IMMUNE RESPONSE.202101349349102070
2020The Rockefeller University New York, NYB$100,000paidTO FUND THE RECIPIENTS RESEARCH AND OPERATING BUDGET.202101349349102070

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Source filings

Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.

Returns this page is derived from
FormTax yearPeriod endFiledSchemaIRS OBJECT_ID
990PF20242024-12-31not stated2024v5.2202533109349100303
990PF20232023-12-31not stated2023v5.1202413169349100806
990PF20222022-12-31not stated2022v5.0202333179349102783
990PF20202020-12-31not stated2020v4.1202101349349102070

Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/357211744.json.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.